14.75

4.09% 0.5833

Perrigo Company Plc (PRGO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Perrigo Company Plc stock is traded at $14.75, with a volume of 2.81M. It is up +4.09% in the last 24 hours and up +9.75% over the past month. Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Previous Close:

$14.17

Open:

$14.23

24h Volume:

2.81M

Relative Volume:

0.81

Market Cap:

$2.03B

Revenue:

$4.39B

Net Income/Loss:

$-159.70M

P/E Ratio:

-12.61

EPS:

-1.17

Net Cash Flow:

$151.70M

1W Performance:

+5.81%

1M Performance:

+9.75%

6M Performance:

-45.77%

1Y Performance:

-41.75%

1-Day Range:

$14.23

$14.80

1-Week Range:

$13.78

$14.80

52-Week Range:

$12.17

$30.93

Perrigo Company Plc Stock (PRGO) Company Profile

Name

Perrigo Company Plc

Sector

Healthcare (1126)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

269-673-8451

Address

THE SHARP BUILDING, DUBLIN 2

Employee

8,379

Twitter

@perrigocompany

Next Earnings Date

2024-11-06

Latest SEC Filings

PRGO's Discussions on Twitter

Compare PRGO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRGO Perrigo Company Plc	14.76	1.95B	4.39B	-159.70M	151.70M	-1.17
ZTS Zoetis Inc	129.44	57.01B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.80	49.57B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.24	45.02B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.06	35.57B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	502.89	21.08B	3.08B	1.24B	1.07B	25.61

Perrigo Company Plc Stock (PRGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-06-25	Downgrade	JP Morgan	Overweight → Neutral
Jan-14-25	Downgrade	Argus	Buy → Hold
Jan-06-25	Downgrade	Piper Sandler	Overweight → Neutral
Sep-24-24	Resumed	Jefferies	Hold
Nov-17-23	Initiated	Piper Sandler	Overweight
Mar-07-23	Initiated	Canaccord Genuity	Buy
Sep-14-22	Upgrade	Argus	Hold → Buy
Sep-06-22	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-14-21	Upgrade	Raymond James	Mkt Perform → Outperform
Sep-30-21	Upgrade	Jefferies	Hold → Buy
Apr-07-21	Resumed	RBC Capital Mkts	Sector Perform
Jan-06-21	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Apr-17-20	Downgrade	Argus	Buy → Hold
Mar-24-20	Upgrade	JP Morgan	Neutral → Overweight
Mar-20-20	Upgrade	SVB Leerink	Mkt Perform → Outperform
Mar-18-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Oct-11-19	Upgrade	Argus	Hold → Buy
Mar-20-19	Initiated	SunTrust	Hold
Nov-13-18	Downgrade	Berenberg	Buy → Hold
Aug-10-18	Reiterated	Stifel	Hold
Jul-30-18	Downgrade	Argus	Buy → Hold
Jul-12-18	Downgrade	Goldman	Neutral → Sell
Jan-03-18	Initiated	Leerink Partners	Mkt Perform
Dec-08-17	Upgrade	Argus	Hold → Buy
Nov-10-17	Upgrade	RBC Capital Mkts	Underperform → Sector Perform
Oct-05-17	Reiterated	UBS	Buy
Sep-07-17	Initiated	Oppenheimer	Outperform
Aug-11-17	Upgrade	Goldman	Sell → Neutral
Aug-11-17	Reiterated	RBC Capital Mkts	Underperform
Jun-16-17	Initiated	Cantor Fitzgerald	Overweight
Jun-05-17	Downgrade	RBC Capital Mkts	Sector Perform → Underperform
Mar-03-17	Reiterated	B. Riley & Co.	Neutral

View All

Perrigo Company Plc Stock (PRGO) Latest News

03:21 AM

PERRIGO CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire

03:21 AM

11:59 AM

Levi & Korsinsky Reminds Perrigo Company plc Investors of the Pe - GuruFocus

11:59 AM

10:08 AM

Portnoy Law Firm Announces Class Action on Behalf of Perrigo Company plc Investors - GlobeNewswire

10:08 AM

09:00 AM

Levi & Korsinsky Reminds Perrigo Company plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 16, 2026PRGO - Morningstar

09:00 AM

Jan 05, 2026

Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who - GlobeNewswire

Jan 05, 2026

Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.

Jan 05, 2026

Bronstein, Gewirtz & Grossman LLC Urges Perrigo Company plc - GlobeNewswire

Jan 05, 2026

Shareholders that lost money on Perrigo Company plc(PRGO) should - GuruFocus

Jan 05, 2026

Shareholders that lost money on Perrigo Company plc(PRGO) should contact The Gross Law Firm about pending Class ActionPRGO - marketscreener.com

Jan 05, 2026

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Jan 05, 2026

Jan 04, 2026

PRGO DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Perrigo Company plc Investors to Secure ... - Bluefield Daily Telegraph

Jan 04, 2026

Jan 02, 2026

PRGO: Kirby McInerney LLP Advises Perrigo Company plc Investors of Class Action Lawsuit - Business Wire

Jan 02, 2026

Perrigo Company plc Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your RightsPRGO - The Malaysian Reserve

Jan 02, 2026

Jan 01, 2026

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire

Jan 01, 2026

PRGO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Perrigo Company plc Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Jan 01, 2026

Dec 31, 2025

PRGO Investors Have Opportunity to Lead Perrigo Company plc Secu - GuruFocus

Dec 31, 2025

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit - Cherokee Tribune

Dec 31, 2025

PRGO DEADLINE NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Perrigo Company plc ... - Caledonian Record

Dec 31, 2025

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire

Dec 31, 2025

Dec 30, 2025